Vaccines

Vaccines continue to offer the key line of protection against a range of infectious diseases; however, the range of vaccines currently available is limited. One key consideration in the development of a vaccine is risk-versus-benefit, and in an environment of perceived low risk, the benefit of vaccination may not be recognised. To address this, there has been a move towards the use of subunit-based vaccines, which offer low side-effect profiles but are generally weakly immunogenic. This can be compensated for by the development of effective adjuvants. Nanotechnology offers key attributes in this field through the ability of nanoparticulates to incorporate and protect antigens from rapid degradation, combined with their potential to effectively deliver the antigens to appropriate cells within the immune system. These characteristics can be exploited in the development of new adjuvants. This chapter will outline the applications of nanosystems in vaccine formulations and consider the mechanisms of action behind a range of formulations.

Fungicidas protetores no manejo da ferrugem da soja, processos fisiológicos e produtividade da cultura

Currently, the management recommendations for asian soybean rust (ASR) has been based on the application of protective fungicides mixed with triazoles and stronilurins. Thus, this study aimed at assessing whether the increased productivity provided by the application of protective fungicides is due solely to the fungicidal action of the product or some physiological changes in the plant and which the latter would be. The experiment was conducted from March to July 2015 at the experimental station of Udi Research and Development in Uberlândia-MG, with the cultivar 97Y07 RR. The experimental design chosen for this study was comprised of a randomized block with four replications and 16 treatments: check, fluxapyroxad + pyraclostrobin (116.55 + 58.45 g ha-1), azoxystrobin + benzovindiflupir (90 + 45 g ha-1), trifloxystrobin + prothioconazole (60 + 70 g ha-1), tebuconazole + picoxystrobin (100 + 60 g ha-1), picoxystrobin + cyproconazole (60 + 24 g ha-1), mancozeb (1125 g ha-1), azoxistrobina + tebuconazole + difenoconazole (60 + 75 + 120 g ha-1), azoxystrobin + tebuconazole + difenoconazole + chlorothalonil ( 60 + 120 + 75 + 1440 g ha-1), and mistures fluxapyroxad + pyraclostrobin + mancozeb, azoxystrobin + benzovindiflupir + mancozeb, trifloxystrobin + prothioconazole + mancozeb, tebuconazole + picoxystrobin + mancozeb, picoxystrobin + cyproconazole + mancozeb, azoxystrobin + tebuconazole + difenoconazole + mancozeb, and azoxystrobin + benzovindiflupir + chlorothalonil, from the aforesaid doses. The first application of the treatments occurred in R1, in the absence of symptoms. The number of applications, intervals and the use of adjuvants were performed according to the recommendations by manufacturers. The variables analyzed were: disease severity, concentration of chlorophylls and carotenoids, photosynthetic rate (A), transpiration rate (E), stomatal conductance (gs), internal carbon concentration (Ci), instantaneous efficiency in water use (A/E), intrinsic water use efficiency (A/gs), and carboxylation efficiency (A/C). With these data collected, this study set to date the progress curve of each variable (AUPC). At the end of the crop cycle, the average of pods per plant was quantified, grain per pod, productivity and weight of 1,000 grains. It was concluded that: the addition of mancozeb to fluxapyroxad + pyraclostrobin, azoxystrobin + benzovindiflupir, trifloxystrobin + prothioconazole and tebuconazole + picoxystrobin potentiated the ASR control; adding mancozebe to the mixture azoxystrobin + benzovindiflupir provided better control of the disease compared to the addition of chlorothalonil; mancozeb amounts to AUPC concentration of photosynthetic pigments and when added to axozystrobin + tebuconazole + difenoconazole, increases the AUPC for total chlorophyll concentration, as well as when chlorothalonil was added; mancozeb added to the mix fluxapyroxad + pyraclostrobin raised the AUPC for A/Ci and A/gs, increasing the W1,000G and crop productivity; the addition of protectors similarly reflected on the productivity of culture.

The administration route is decisive for the ability of the vaccine adjuvant CAF09 to induce antigen-specific CD8+ T-cell responses:the immunological consequences of the biodistribution profile

A prerequisite for vaccine-mediated induction of CD8+ T-cell responses is the targeting of dendritic cell (DC) subsets specifically capable of cross-presenting antigen epitopes to CD8+ T cells. Administration of a number of cationic adjuvants via the intraperitoneal (i.p.) route has been shown to result in strong CD8+ T-cell responses, whereas immunization via e.g. the intramuscular (i.m.) or subcutaneous (s.c.) routes often stimulate weak CD8+ T-cell responses. The hypothesis for this is that self-drainage of the adjuvant/antigen to the lymphoid organs, which takes place upon i.p. immunization, is required for the subsequent activation of cross-presenting lymphoid organ-resident CD8α+ DCs. In contrast, s.c. or i.m. immunization usually results in the formation of a depot at the site of injection (SOI), which hinders the self-drainage and targeting of the vaccine to cross-presenting CD8α+ DCs. We investigated this hypothesis by correlating the biodistribution pattern and the adjuvanticity of the strong CD8+ T-cell inducing liposomal cationic adjuvant formulation 09 (CAF09), which is composed of dimethyldioctadecylammonium bromide/monomycoloyl glycerol liposomes with polyinosinic:polycytidylic acid electrostatically adsorbed to the surface. Biodistribution studies with radiolabeled CAF09 and a surface-adsorbed model antigen [ovalbumin (OVA)] showed that a significantly larger fraction of the vaccine dose localized in the draining lymph nodes (dLNs) and the spleen 6 h after i.p. immunization, as compared to after i.m. immunization. Studies with fluorescently labelled OVA + CAF09 demonstrated a preferential association of OVA + CAF09 to DCs/monocytes, as compared to macrophages and B cells, following i.p. immunization. Administration of OVA + CAF09 via the i.p. route did also result in DC activation, whereas no DC activation could be measured within the same period with unadjuvanted OVA and OVA + CAF09 administered via the s.c. or i.m. routes. In the dLNs, the highest level of activated, cross-presenting CD8α+ DCs was detected at 24 h post immunization, whereas an influx of activated, migrating and cross-presenting CD103+ DCs to the dLNs could be measured after 48 h. This suggests that the CD8α+ DCs are activated by self-draining OVA + CAF09 in the lymphoid organs, whereas the CD103+ DCs are stimulated by the OVA + CAF09 at the SOI. These results support the hypothesis that the self-drainage of OVA + CAF09 to the draining LNs is required for the activation of CD8α+ DCs, while the migratory CD103+ DCs may play a role in sustaining the subsequent induction of strong CD8+ T-cell responses.

Rapid quantification and validation of lipid concentrations within liposomes

Quantification of the lipid content in liposomal adjuvants for subunit vaccine formulation is of extreme importance, since this concentration impacts both efficacy and stability. In this paper, we outline a high performance liquid chromatography-evaporative light scattering detector (HPLC-ELSD) method that allows for the rapid and simultaneous quantification of lipid concentrations within liposomal systems prepared by three liposomal manufacturing techniques (lipid film hydration, high shear mixing, and microfluidics). The ELSD system was used to quantify four lipids: 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC), cholesterol, dimethyldioctadecylammonium (DDA) bromide, and D-(+)-trehalose 6,6′-dibehenate (TDB). The developed method offers rapidity, high sensitivity, direct linearity, and a good consistency on the responses (R2 > 0.993 for the four lipids tested). The corresponding limit of detection (LOD) and limit of quantification (LOQ) were 0.11 and 0.36 mg/mL (DMPC), 0.02 and 0.80 mg/mL (cholesterol), 0.06 and 0.20 mg/mL (DDA), and 0.05 and 0.16 mg/mL (TDB), respectively. HPLC-ELSD was shown to be a rapid and effective method for the quantification of lipids within liposome formulations without the need for lipid extraction processes.

Effet des pesticides MCPA et imidaclopride sur la régulation des voies de signalisation du récepteur à la dioxine (AhR) et au récepteur aux androgènes (AR)

Avec l’ère industrielle sont venus les polluants environnementaux. Ils sont de plus en plus pointés du doigt pour une variété d’effets indésirables en particulier pour leur potentiel à affecter la santé humaine. Les pesticides font partie de ces polluants et leurs usages ne font que croître depuis une vingtaine d’années. Ces produits qui servent à améliorer la production agricole en éliminant les pestes qui ravagent les récoltes sont souvent peu étudiés à long terme avant d’être homologués. L’effet perturbateur au niveau cellulaire et les effets à long terme de ces pesticides sont peu connus. Pour ce projet de maîtrise, nous avons observé l’effet de deux pesticides, l’imidaclopride et l’acide 2-methyl-4-chlorophenoxyacetic (MCPA), sur les voies de signalisation du récepteur à la dioxine (AhR) et du récepteur aux androgènes (AR). L’imidaclopride est un insecticide de la famille des néonicotinoïdes, une classe de plus en plus utilisée. Ce pesticide est surtout connu pour être en lien avec le déclin des colonies d’abeilles depuis une décennie. Le MCPA est un des herbicides les plus utilisés au Québec, il est persistant et souvent retrouvé dans les eaux de la province. Nous avons traité des cellules du cancer du sein et des cellules du cancer de la prostate avec ces pesticides et nous avons vérifié si leur présence perturbait les deux voies de signalisation cellulaire à l’étude. Le récepteur AhR est un facteur de transcription activé par un ligand. Le TCDD, une dioxine, est le meilleur ligand exogène connu à ce jour de ce récepteur. Par contre, ses ligands naturels, des dérivés du tryptophane ou des facteurs de virulence de bactéries, l’activent de façon beaucoup moins forte. Lors de l’activation de la voie AhR, les gènes CYP1A1 et CYP1B1 sont transcrits et codent pour des enzymes du cytochrome P450 qui transforment les ligands en produits plus facilement éliminables. Dans un contexte où de l’œstradiol (E2) est présent dans les cellules, il y a une interaction croisée entre le récepteur à l’œstrogène (ER) et le récepteur AhR, qui fait en sorte que l’expression de CYP1A1 est réprimée. Cela se traduit en un ratio d’enzyme CYP1A1 à CYP1B1 différent qui pourrait augmenter la possibilité d’une accumulation de métabolites génotoxiques. En effet, CYP1B1 hydroxyle le ligand d’AhR mais aussi l’œstradiol en 4-hydroxyœstradiol (4-OHE), dont l’accumulation peut amener des mutations dans l’ADN alors que l’enzyme CYP1A1 l’hydroxyle en 2-hydroxyœstradiol (2-OHE), qui n’as aucun effet néfaste répertorié sur la cellule. Dans les cellules du cancer du sein, le MCPA appliqué en champs induisait fortement l’expression de CYP1B1 comparable à l’échantillon traité au témoin positif (TCDD), alors que CYP1A1 l’était que très légèrement par rapport au témoin non-traité. Au niveau protéique, CYP1A1 n’était qu’exprimée dans le témoin positif (TCDD) et ce, en quantité moindre lorsqu’il y avait présence d’œstradiol. CYP1B1 était fortement exprimée dans l’échantillon de TCDD, ce qui était attendu, mais aussi dans tous les échantillons traités au MCPA de NuFarm. Ces effets ne sont pas notés avec l’ingrédient actif du MCPA. La présence d’un ou plusieurs autres produits ajoutés dans le MCPA de la compagnie NuFarm en combinaison avec l’ingrédient actif pourrait activer la voie de signalisation d’AhR et causer ce débalancement dans l’expression des gènes CYP1A1 et CYP1B1. Nos résultats indiquent que plusieurs concentrations de l’ingrédient actif de l’imidaclopride ne perturbe pas les voies cellulaires d’AhR ni AR, alors que, le MCPA perturbe ces deux voies cellulaires. Par contre, c’est seulement celui produit par la compagnie NuFarm qui est utilisé en champs. Cette formulation appliquée en terrain agricole inclut l’ingrédient actif ainsi que les antigels, les surfactants et les adjuvants qui permettent au produit d’être plus efficace. L’ingrédient actif du MCPA seul n’affectait pas les deux voies. Le récepteur aux androgènes (AR) est aussi un facteur de transcription qui se lie à l’ADN afin de réguler l’expression des gènes et il est particulièrement important pour le développement et le maintien du phénotype masculin. Depuis une vingtaine d’années, des problèmes de baisse de libido et de fertilité s’accentuent dans notre société et semblent être reliés à la baisse de testostérone des hommes (Travison et al. 2007). Cette molécule est d’ailleurs un des deux ligands du récepteur AR, le deuxième étant la 5-dihydrotestostérone (DHT). Le facteur environnemental plutôt que le mode de vie semble être un facteur déterminant dans l’étude qui portait sur ce déclin. Les pesticides ont déjà été soupçonnés pour avoir un potentiel anti-androgénique, mais aucune étude ne fait un lien de causalité direct. Dans le projet de maitrise présenté dans ce document, l’expression des gènes marqueurs PSA (antigène spécifique de la prostate) et PCA3 (antigène du cancer de la prostate) a été quantifiée pour savoir si les pesticides ont un effet perturbateur sur la voie du récepteur AR. Dans les cellules du cancer de la prostate, l’expression de PSA et PCA3 était semblable au non-traité dans l’échantillon traité au MCPA (NuFarm), et ce, même après l’ajout de DHT, qui active l’expression de ces deux gènes. Cette fois-ci, l’ingrédient actif seul faisait en sorte que les deux gènes marqueurs étaient moins exprimés lors de l’ajout de la DHT, par rapport au témoin. Il semblerait que l’ingrédient actif est à la base de ce changement d’expression de nos gènes marqueurs. Donc, le MCPA pourrait avoir un effet anti-androgénique dans les cellules du cancer de la prostate. Donc, le MCPA est un pesticide qui affecte les voies de signalisation cellulaires AhR et AR. Il est particulier de noter que le pesticide appliqué en champ perturbe nettement plus les voies cellulaires. Il sera important de continuer à étudier les effets des pesticides sur l’homme au niveau cellulaire et de comprendre comment ils pourraient contribuer au développement du cancer.

Développement et évaluation pré-clinique de nouveaux vaccins inactivés contre l’influenza et suivi de l’évolution des souches virales A/H3N2

Les virus influenza de type A sont des pathogènes respiratoires causant des épidémies saisonnières et des pandémies de manière plus occasionnelles. Au cours d’une saison, 10 à 20 % de la population mondiale est touchée, ce qui constitue un problème majeur de santé publique. Les virus de sous-type A/H3N2 sont associés à une plus forte morbidité et mortalité que les virus de sous-type A/H1N1. La vaccination reste le moyen le plus efficace de contrôler les infections, cependant l’efficacité de ces vaccins est de courte durée et compromise en cas de non-appariemment entre les souches circulantes et vaccinales. La première partie de cette thèse a été consacrée à l’optimisation des vaccins inactivés A/H3N2 en testant de nouveaux adjuvants et de nouvelles voies d’administration chez la souris et le furet. Nous avons démontré que l’adjuvant AS25 semble prometteur pour le développement de vaccins plus efficaces. La seconde partie de cette thèse a été consacrée à suivre l’évolution moléculaire et antigénique des souches A/H3N2 circulantes au Québec entre 2009 et 2011. Notre conclusion est qu’il n’y a pas que le nombre de mutations dans la HA qui est important, en ce sens que la nature et la localisation de ces dernières jouent un rôle clé lors d’une dérive antigénique. Après avoir suivi les souches A/H3N2 sous pression immunitaire, nous avons suivi dans la troisième partie de cette thèse une souche A/H3N2 sous pression d’un nouvel antiviral; le laninamivir. Les antiviraux sont la première ligne de défense en cas de pandémie ou lors d’une épidémie lorsqu’il y a un mésappariemment entre les souches circulante et vaccinale. Notre conclusion est que la réplication de notre mutant est conservé in vitro mais non in vivo. Les différentes expériences effectuées au cours de cette thèse ont permis de suivre l’évolution des souches A/H3N2 et de mettre en œuvre de nouveaux moyens de prévention et de traitement.

Processo de transição da pessoa estomizada da depêndencia de cuidado ao autocuidado: subsídios à enfermagem

Objetivou-se conhecer como a pessoa com estomia vivência o processo de transição da dependência de cuidados ao autocuidado à luz da Teoria das Transições de Meleis. Pesquisa exploratória, descritiva com abordagem qualitativa no Serviço de Estomaterapia do Hospital Universitário Dr Miguel Riet Corrêa Jr do Rio Grande/ RS/ Brasil com 27 pessoas com estomias definitivas por câncer. Os dados foram coletados nos mês de janeiro e fevereiro de 2014 por meio de entrevista com roteiro semiestruturado e submetidos à Análise de Conteúdo apoiada nas ideias da Teoria das Transições de Afaf I. Meleis. Constatou-se que a natureza da transição situou-se no processo tipo saúde/doença. A entrada no processo de transição deu-se a partir da consciência desencadeada pelo diagnóstico de câncer, reforçado pela cirurgia de estomização. O empenhamento surge ao dedicarem-se a construção do conhecimento para o autocuidado frente às mudanças na sua vida e na sua nova relação com seu corpo, mudando a visão de si, do mundo e dos outros. Destacou-se o espaço temporal como algo dinâmico e variavelmente indeterminável, sendo fundamental para que se organizem e reflitam acerca do seu novo viver, fortalecendo-se para que a transição progrida. Verificaram-se como fatores facilitadores do autocuidado a construção de um significado positivo à estomização, o preparo dessa experiência ainda no pré-operatório, a estabilidade emocional, a fé e a religiosidade e a sensação de normalidade adquirida a partir de uma imagem próxima da anterior. Referiram-se, ainda, ao fornecimento de forma gratuita pelo governo das bolsas coletoras, adjuvantes e acessórios e ao atendimento da equipe multiprofissional. Como fatores inibidores do processo de transição encontraram-se a visão distorcida de seu corpo, o despreparo para viver com a estomia, a instabilidade emocional, a desmotivação com afastamento de atividades prazerosas, o cuidado excessivo e/ou estendido e até mesmo a superproteção da família, as complicações como hérnias e prolapsos, a falta de atitudes positivas quanto à vida, a negação da bolsa coletora, as tentativas frustradas de omitir o uso da bolsa coletora, a falta do domínio do manuseio dos equipamentos, o afastamento do trabalho e as dificuldades financeiras. Além destas, o abandono do parceiro, atitudes negativas e estigmatizantes por parte da família e a baixa qualidade dos materiais fornecidos pelo governo. Como indicadores de resultados identificaram-se a confiança para realizar atividades anteriores, aceitação de sua situação, uma visão positiva de sua vida e da capacidade de compartilhar o seu cuidado com sua família. Considera-se a saída da transição quando este for capaz de dominar novas competências tanto para o cuidado físico ao realizar a troca da bolsa coletora quanto readequando sua imagem e autoconceito. Concluiu-se que o processo de transição da dependência de cuidados ao autocuidado da pessoa com estomia é complexo e carregado de subjetividades. É necessário que o enfermeiro estabeleça ações terapêuticas de enfermagem eficazes e eficientes, contribuindo para a promoção e reabilitação da saúde deste, auxiliando-o na aquisição de sua autonomia e independência, subsidiando seu autocuidado e bem-estar.

Efficient and Durable Vaccine against Intimin β of Diarrheagenic E. Coli Induced by Clay Nanoparticles

Improved strategies are urgently required to control infections with enterohemorrhagic Escherichia coli and enteropathogenic E. coli, two dominant zoonotic enteric pathogens responsible for a wide spectrum of illnesses as well as deaths of human being, with tremendous financial cost worldwide. The present study investigates the capacity of two clay nanoparticles (NPs) with opposite surface charges, namely synthetic layered double hydroxide (LDH) and hectorite (HEC) NPs as adjuvants to promote strong immune responses against the infections. Here both LDH and HEC NPs are showed to be able to carry an appreciable amount of Intimin β (1.1 and 4.4 mg per mg clay nanomaterials, respectively) and significantly facilitate antigen uptake by antigen-presenting cells. Remarkably, these clay NPs induce strong antibody and cell-mediated immune responses, which are much higher than that by the potent adjuvant, QuilA. Furthermore, these strong immune responses are well maintained for at least four months in the mouse model, during which there are no changes in histopathology of the animal organs. Collectively these data demonstrate the suitability of LDH and HEC NPs as useful adjuvants in new-generation vaccine formulations to control various infectious diseases.

Extraction and purification of immunoglobulin G with aqueous biphasic systems

The immune system is able to produce antibodies, which have the capacity to recognize and to bind to foreign molecules or pathogenic organisms. Currently, there are a diversity of diseases that can be treated with antibodies, like immunoglobulins G (IgG). Thereby, the development of cost-efficient processes for their extraction and purification is an area of main interest in biotechnology. Aqueous biphasic systems (ABS) have been investigated for this purpose, once they allow the reduction of costs and the number of steps involved in the process, when compared with conventional methods. Nevertheless, typical ABS have not showed to be selective, resulting in low purification factors and yields. In this context, the addition of ionic liquids (ILs) as adjuvants can be a viable and potential alternative to tailor the selectivity of these systems. In this work, ABS composed of polyethylene glycol (PEG) of different molecular weight, and a biodegradable salt (potassium citrate) using ILs as adjuvants (5 wt%), were studied for the extraction and purification of IgG from a rabbit source. Initially, it was tested the extraction time, the effect on the molecular weight of PEG in a buffer solution of K3C6H5O7/C6H8O7 at pH≈7, and the effect of pH (59) on the yield (YIgG) and extraction efficiency (EEIgG%) of IgG. The best results regarding EEIgG% were achieved with a centrifugation step at 1000 rpm, during 10 min, in order to promote the separation of phases followed by 120 min of equilibrium. This procedure was then applied to the remaining experiments. The results obtained in the study of PEGs with different molecular weights, revealed a high affinity of IgG for the PEG-rich phase, and particularly for PEGs of lower molecular weight (EEIgG% of 96 % with PEG 400). On the other hand, the variation of pH in the buffer solution did not show a significant effect on the EEIgG%. Finally, it was evaluated the influence of the addition of different ILs (5% wt) on the IgG extraction in ABS composed of PEG 400 at pH≈7. In these studies, it was possible to obtain EEIgG% of 100% with the ILs composed of the anions [TOS]-, [CH3CO2]-and Cl-, although the obtained YIgG% were lower than 40%. On the other hand, the ILs composed of the anions Br-, as well as of the cation [C10mim]+, although not leading to EEIgG% of 100%, provide an increase in the YIgG%. ABS composed of PEG, a biodegradable organic salt and ILs as adjuvants, revealed to be an alternative and promising method to purify IgG. However, additional studies are still required in order to reduce the loss of IgG.

A randomised controlled trial comparing the effect of adjuvant intrathecal 2 mg midazolam to 20 micrograms fentanyl on postoperative pain for patients undergoing lower limb orthopaedic surgery under spinal anaesthesia.

Background: Intrathecal adjuvants are added to local anaesthetics to improve the quality of neuraxial blockade and prolong the duration of analgesia during spinal anaesthesia. Used intrathecally, fentanyl improves the quality of spinal blockade as compared to plain bupivacaine and confers a short duration of post-operative analgesia. Intrathecal midazolam as an adjuvant has been used and shown to improve the quality of spinal anaesthesia and prolong the duration of post-operative analgesia. No studies have been done comparing intrathecal fentanyl with bupivacaine and intrathecal 2 mg midazolam with bupivacaine. Objective: To compare the effect of intrathecal 2 mg midazolam to intrathecal 20 micrograms fentanyl when added to 2.6 ml of 0.5% hyperbaric bupivacaine, on post-operative pain, in patients undergoing lower limb orthopaedic surgery under spinal anaesthesia. Methods: A total of 40 patients undergoing lower limb orthopaedic surgery under spinal anaesthesia were randomized to two groups. Group 1: 2.6mls 0.5% hyperbaric bupivacaine with 0.4mls (20micrograms) fentanyl Group 2: 2.6mls of 0.5% hyperbaric bupivacaine with 0.4mls (2mg) midazolam Results: The duration of effective analgesia was longer in the midazolam group (384.05 minutes) as compared to the fentanyl group (342.6 minutes). There was no significant difference (P 0.4047). The time to onset was significantly longer in midazolam group 17.1 minutes as compared to the fentanyl group 13.2 minutes (P 0.023). The visual analogue score at rescue was significantly lower in the midazolam group (5.55) as compared to the fentanyl group 6.35 (P - 0.043). Conclusion: On the basis of the results of this study, there was no significant difference in the duration of effective analgesia between adjuvant intrathecal 2 mg midazolam as compared to intrathecal 20 micrograms fentanyl for patients undergoing lower limb orthopaedic surgery.

Influence of enzymes and technology on the composition of Cobrançosa and Galega vulgar virgin olive oils

Doutoramento em Engenharia Alimentar - Instituto Superior de Agronomia - UL

In silico adjuvant design and validation

Adjuvants are substances that boost the protective immune response to vaccine antigens. The majority of known adjuvants have been identified through the use of empirical approaches. Our aim was to identify novel adjuvants with well-defined cellular and molecular mechanisms by combining a knowledge of immunoregulatory mechanisms with an in silico approach. CD4 + CD25 + FoxP3 + regulatory T cells (Tregs) inhibit the protective immune responses to vaccines by suppressing the activation of antigen presenting cells such as dendritic cells (DCs). In this chapter, we describe the identification and functional validation of small molecule antagonists to CCR4, a chemokine receptor expressed on Tregs. The CCR4 binds the chemokines CCL22 and CCL17 that are produced in large amounts by activated innate cells including DCs. In silico identified small molecule CCR4 antagonists inhibited the migration of Tregs both in vitro and in vivo and when combined with vaccine antigens, significantly enhanced protective immune responses in experimental models.

Using Different Co-Adjuvant Activating Agents to Improve Activated Carbon Adsorption Capacities

Activated carbon (AC) has proved to be an effective adsorbent for the removal of an assortment of organic and inorganic pollutants from aqueous or gaseous media. However, the pursuit for more effective and cheaper AC is still very active and a diversity of textural and chemical treatments are described as a way to expand their applications. It is well known that the surface area and surface chemistry of AC strongly affect their adsorption capacity [1-3]. In particular, an increase in the nitrogen content has been related to an increase of the basic character and also to the development of the porous structure. In most published work this was achieved through an AC post treatment, including either a reaction with nitrogen containing reagents, such as ammonia, nitric acid, or a diversity of amines. However, the AC prepared directly from a nitrogen rich precursor through a physical or chemical activation is referred to as presenting the best characteristics, namely high nitrogen content, high basic character, low nitrogen leaching and also a good thermal stability [4]. To improve the AC adsorption capacities for acidic pesticide removal from the aqueous phase, we intend to improve the porous structure and introduce nitrogenated groups directly into the AC matrix, using different co-adjuvant activating agents as a nitrogen source, by chemical activation, with potassium hydroxide, of cork or poly(ethyleneterephthalate) (PET) precursors.